Impaired PARP1 DNA repair defines chemo-sensitivity in IDH1 mutant cell

被引：0
|
作者：
Yang, Chunzhang [1 ]
Lu, Yanxin [1 ]
Liu, Yang [1 ]
Gilbert, Mark [1 ]
Wu, Jing [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2993
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impaired PARP1 DNA repair defines chemosensitivity in IDH1 mutant cell
    Lu, Yanxin
    Liu, Yang
    Su, Yu-Ting
    Bautista, Wendy
    Gilbert, Mark R.
    Wu, Jing
    Yang, Chunzhang
    CANCER RESEARCH, 2017, 77
  • [2] IMPAIRED PARP1 DNA REPAIR DEFINES CHEMOSENSITIVITY IN IDH1 MUTANT CELL
    Lu, Yanxin
    Liu, Yang
    Wu, Jing
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2017, 19 : 89 - 89
  • [3] IMPAIRED PARP1 DNA REPAIR DEFINES CHEMOSENSITIVITY IN IDH1-MUTATED CELL
    Lu, Yanxin
    Liu, Yang
    Gilbert, Mark
    Wu, Jing
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2018, 20 : 102 - 102
  • [4] Mutant IDH1 is required for IDH1 mutated tumor cell growth
    Jin, Genglin
    Pirozzi, Christopher J.
    Chen, Lee H.
    Lopez, Giselle Y.
    Duncan, Christopher G.
    Feng, Jie
    Spasojevic, Ivan
    Bigner, Darell D.
    He, Yiping
    Yan, Hai
    ONCOTARGET, 2012, 3 (08) : 774 - 782
  • [5] Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
    Inoue, Satoshi
    Li, Wanda Y.
    Tseng, Alan
    Beerman, Isabel
    Elia, Andrew J.
    Bendall, Sean C.
    Lemonnier, Francois
    Kron, Ken J.
    Cescon, David W.
    Hao, Zhenyue
    Lind, Evan F.
    Takayama, Naoya
    Planello, Aline C.
    Shen, Shu Yi
    Shih, Alan H.
    Larsen, Dana M.
    Li, Qinxi
    Snow, Bryan E.
    Wakeham, Andrew
    Haight, Jillian
    Gorrini, Chiara
    Bassi, Christian
    Thu, Kelsie L.
    Murakami, Kiichi
    Elford, Alisha R.
    Ueda, Takeshi
    Straley, Kimberly
    Yen, Katharine E.
    Melino, Gerry
    Cimmino, Luisa
    Aifantis, Iannis
    Levine, Ross L.
    De Carvalho, Daniel D.
    Lupien, Mathieu
    Rossi, Derrick J.
    Nolan, Garry P.
    Cairns, Rob A.
    Mak, Tak W.
    CANCER CELL, 2016, 30 (02) : 337 - 348
  • [6] Targeting IDH1/2 mutant cancers with unique combinations of DNA repair inhibitors
    Sule, Amrita D.
    Sundaram, Ranjini
    Bindra, Ranjit
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Functional Aspects of PARP1 in DNA Repair and Transcription
    Ko, Hui Ling
    Ren, Ee Chee
    BIOMOLECULES, 2012, 2 (04) : 524 - 548
  • [8] FTO suppresses DNA repair by inhibiting PARP1
    Tianyi Zhu
    Jing Zhi Anson Tan
    Lingrui Zhang
    He Huang
    Sooraj S. Das
    Flora Cheng
    Pranesh Padmanabhan
    Mathew J. K. Jones
    Mihwa Lee
    Albert Lee
    Jocelyn Widagdo
    Victor Anggono
    Nature Communications, 16 (1)
  • [9] IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
    Molenaar, Remco J.
    Radivoyevitch, Tomas
    Nagata, Yasunobu
    Khurshed, Mohammed
    Przychodzen, Bartolomiej
    Makishima, Hideki
    Xu, Mingjiang
    Bleeker, Fonnet E.
    Wilmink, Johanna W.
    Carraway, Hetty E.
    Mukherjee, Sudipto
    Sekeres, Mikkael A.
    van Noorden, Cornelis J. F.
    Maciejewski, Jaroslaw P.
    CLINICAL CANCER RESEARCH, 2018, 24 (07) : 1705 - 1715
  • [10] Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors
    Sule, Amrita
    Van Doorn, Jinny
    Sundaram, Ranjini K.
    Ganesa, Sachita
    Vasquez, Juan C.
    Bindra, Ranjit S.
    NAR CANCER, 2021, 3 (02):
12345